Ligand to Report Fourth Quarter Financial Results on February 17
Go back to Ligand to Report Fourth Quarter Financial Results on February 17| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 280.00 -6.29 (2.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.29 | 52 Week High | $139.79 | |||
| Open | $286.27 | 52 Week Low | $82.07 | |||
| Day High | $286.27 | P/E | 651.16 | |||
| Day Low | $280.00 | EPS | $0.43 | |||
| Volume | 126,159 | |||||

